How Does Long-Term Storage Influence the Physical Stability and Dissolution of Bicalutamide from Solid Dispersions and Minitablets?

The stability of amorphous drugs is among the main challenges in the development of solid dosage forms. This paper examines the effect of storage conditions (25 °C/60% RH and 40 °C/75% RH) and different packaging materials, i.e., polystyrene containers and PVC/Al blisters, on the crystallinity and dissolution characteristics of solid dispersions containing bicalutamide and polyvinylpyrrolidone. The results confirmed drug amorphization upon milling and improved dissolution resulting from the lack of a crystal lattice. These properties varied with time regarding sample composition, storage conditions, and packaging material. The most resistant to storage conditions was the 1:1 solid dispersion packed into blisters. Based on the obtained results, the 1:1 solid dispersion was formulated into minitablets, which were then tested after tableting and then packed into PVC/Al blisters and stored for six months in the same conditions as solid dispersions. We proved that efficient stabilization of amorphous bicalutamide depends on the barrier properties of packaging materials and that a properly chosen material protected the drug substance from the influence of unfavorable storage conditions such as elevated temperature and humidity.

[1]  Juyoung Kim,et al.  Utilization of a compaction simulator to formulate mini-tablets containing high dose of acyclovir , 2021 .

[2]  C. Luebbert,et al.  Phase behavior of ASDs based on hydroxypropyl cellulose , 2020, International journal of pharmaceutics: X.

[3]  P. Kleinebudde,et al.  Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions , 2020, International journal of pharmaceutics: X.

[4]  Zhen Liu,et al.  The Development of Minitablets for a Pediatric Dosage Form for a Combination Therapy. , 2020, Journal of pharmaceutical sciences.

[5]  R. Jachowicz,et al.  Tabletting solid dispersions of bicalutamide prepared using ball-milling or supercritical carbon dioxide: the interrelationship between phase transition and in-vitro dissolution , 2020, Pharmaceutical development and technology.

[6]  M. Repka,et al.  Manufacturing strategies to develop amorphous solid dispersions: An overview. , 2020, Journal of drug delivery science and technology.

[7]  J. Huwyler,et al.  Mechanisms of increased bioavailability through amorphous solid dispersions: a review , 2019, Drug delivery.

[8]  K. Ryan,et al.  From batch to continuous - New opportunities for supercritical CO2 technology in pharmaceutical manufacturing. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  L. Peltonen Practical guidelines for the characterization and quality control of pure drug nanoparticles and nano‐cocrystals in the pharmaceutical industry☆ , 2018, Advanced drug delivery reviews.

[10]  R. Jachowicz,et al.  Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress , 2018, International journal of pharmaceutics.

[11]  G. Sadowski,et al.  Physical stability of API/polymer‐blend amorphous solid dispersions , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  R. Williams,et al.  Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method. , 2018, Journal of pharmaceutical sciences.

[13]  R. Jachowicz,et al.  Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide. , 2017, International journal of pharmaceutics.

[14]  F. Theil,et al.  Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage. , 2017, Molecular pharmaceutics.

[15]  Bing Wang,et al.  Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  W. Sawicki,et al.  Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  T. Rades,et al.  Recent advances in co-amorphous drug formulations. , 2016, Advanced drug delivery reviews.

[18]  J. Veuthey,et al.  Strategies for formulating and delivering poorly water-soluble drugs , 2015 .

[19]  M. Lawrence,et al.  Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions. , 2013, International journal of pharmaceutics.

[20]  S. Varona,et al.  Solubility of Paracetamol and Polyvinylpyrrolidone in Mixtures of Carbon Dioxide, Ethanol, and Acetone at Elevated Pressures , 2013 .

[21]  Jianfeng Chen,et al.  Formation of bicalutamide nanodispersion for dissolution rate enhancement. , 2011, International journal of pharmaceutics.

[22]  David S. Jones,et al.  Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. , 2010, Journal of pharmaceutical sciences.

[23]  F. Gao,et al.  Characteristics of Bicalutamide Solid Dispersions and Improvement of the Dissolution , 2006, Drug development and industrial pharmacy.

[24]  Geoff G. Z. Zhang,et al.  Phase transformation considerations during process development and manufacture of solid oral dosage forms. , 2004, Advanced drug delivery reviews.

[25]  Bruno C. Hancock,et al.  Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. , 1995, Journal of pharmaceutical sciences.